97 studies found for:    "tumor necrosis factor receptor-associated periodic syndrome" [DISEASE] OR NCT00094900 [ID-NUMBER] OR NCT00442182 [ID-NUMBER] OR NCT01242813 [ID-NUMBER]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS)
Condition: TNF-receptor Associated Periodic Syndromes (TRAPS)
Intervention: Drug: ACZ885
2 Unknown  The Efficacy and Safety of ITF2357 in AIS
Conditions: Autoinflammatory Syndromes;   HIDS;   TRAPS;   Schnitzler's Syndrome
Intervention: Drug: ITF2357
3 Completed
Has Results
Interleukin-1 Trap to Treat Autoinflammatory Diseases
Conditions: Inflammation;   Familial Mediterranean Fever;   Still's Disease, Adult-Onset
Intervention: Drug: IL-1 Trap
4 Completed Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP
Condition: Malaria
Interventions: Biological: Vaccination Schedule One;   Biological: Vaccination Schedule Two;   Biological: Vaccination Schedule Three;   Biological: Vaccination Schedule Four;   Biological: Vaccination Schedule Five;   Biological: Vaccination Schedule Six;   Biological: Vaccination Schedule Seven
5 Completed A Study of AdCh63 ME−TRAP Alone and With MVA ME−TRAP
Condition: Malaria
Interventions: Biological: AdCh63 ME-TRAP;   Biological: AdCh63 ME-TRAP; MVA ME-TRAP
6 Completed Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas
Condition: Malaria
Intervention: Biological: AdCh63 ME-TRAP followed by MVA ME-TRAP
7 Completed AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area
Condition: Malaria
Interventions: Biological: AdCh63 ME-TRAP, MVA ME-TRAP;   Biological: AdCH63 ME-TRAP, MVA ME-TRAP
8 Completed Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP
Condition: Malaria
Interventions: Biological: AdCh63 MSP1, MVA MSP1, challenge;   Biological: AdCh63 AMA1, MVA AMA1, challenge;   Biological: AdCh63 AMA1, AdCh63 MSP1, MVA AMA1, MVA MSP1, challenge;   Biological: AdCh63 MSP1, AdCh63 ME-TRAP, MVA MSP1, MVA ME-TRAP, challenge;   Biological: Sporozoite challenge
9 Completed AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area
Condition: Malaria
Interventions: Biological: AdCh63 ME-TRAP, MVA ME-TRAP;   Biological: HDCRV
10 Recruiting A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants
Condition: Malaria
Intervention: Biological: ChAd63 ME-TRAP / MVA ME-TRAP
11 Recruiting Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: Trap Myelin Test
12 Recruiting Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant
Condition: Bone Marrow Transplant
Intervention:
13 Recruiting Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Conditions: Prematurity;   Necrotizing Enterocolitis
Intervention:
14 Completed The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation
Condition: Heart Disease
Intervention: Procedure: Forearm Venous Occlusion Plethysmography
15 Recruiting Neutrophil Extracellular Traps Formation Post-hematopoietic Stem Cell Transplantation
Condition: Childhood Cancer
Intervention:
16 Recruiting Neutrophil Extracellular Traps (NETs) Formation Following Chemotherapy and Their Role in Antitumor Activity
Conditions: Pediatric Solid Malignancies;   Pediatric Hematological Malignancies
Intervention:
17 Active, not recruiting VEGF Trap-Eye in Vision Impairment Due to DME
Conditions: Diabetes Mellitus;   Macular Edema
Interventions: Biological: VEGF Trap-Eye (BAY86-5321);   Procedure: Laser treatment
18 Completed Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)
Condition: Macular Edema
Intervention: Biological: VEGF Trap-Eye (BAY86-5321)
19 Active, not recruiting Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
Condition: Macular Edema
Interventions: Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321);   Procedure: Laser photocoagulation
20 Completed
Has Results
AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites
Condition: Ovarian Neoplasms
Intervention: Drug: Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years